News and feature stories about the Department of Neurology at Indiana University School of Medicine.
Recent News
Over the past year-and-a-half, more than 100 people have received new disease-modifying drugs for Alzheimer’s disease at the Indiana University Health Neuroscience Center in downtown Indianapolis, and that number grows weekly. Not only are the patients among the first people in the country to receive the treatment, but they’re contributing to the work of researchers from the IU School of Medicine who are actively studying the long-term effects of the drugs.
April 24, 2025
Every 70 to 90 seconds, someone in the United States has a stroke or a mini stroke. Large vessel occlusions, which require a thrombectomy, account for 10-15% of total ischemic strokes. A multicenter study led by Kaustubh Limaye, MD, an associate professor of clinical neurology, neurological surgery and radiology and imaging sciences at the IU School of Medicine found that a novel device used to surgically treat patients with large vessel occlusions — a severe type of ischemic stroke — is a safe and effective way to remove blood clots in the brain.
April 23, 2025
Parkinson's researchers discover 'tip of the ICE-berg' on quest for a cure
Parkinson's researcher Malú Tansey brings cell-level science to IU’s already strong clinical research program. Her lab engages in "paradigm-shifting work" studying inflammation and immune response in Parkinson's.March 31, 2025
Symposium invites community, scientific leaders to better understand brain health, neurodegeneration
The IU School of Medicine will highlight its robust neuroscience research program April 13 and 14 at the inaugural Center for Neurodegenerative Disorders Symposium.
March 26, 2025
Malú Tansey, PhD and her team of researchers like to think “outside the brain.” Her lab investigates the role of inflammation and immune system responses on brain health and the development of neurodegenerative diseases, such as Alzheimer’s disease, Parkinson’s disease and frontal temporal dementia, with a specific focus on the gut-brain connection.
October 21, 2024
IU-led early-onset Alzheimer's study expands globally
The largest study of early-onset Alzheimer's disease in the United States, headquartered at the Indiana University School of Medicine, is growing to include five new sites in Europe and South America.
August 07, 2024
Paige Logan, a laboratory research specialist and lab manager at the Indiana University School of Medicine was selected as the lead ambassador for the Alzheimer's Association's ISTAART program for 2024-25. She’s in charge of guiding this year’s cohort of ambassadors — 38 early career researchers representing 24 countries.
July 26, 2024
Alzheimer's disease basic science finding leads to clinical trial
A novel therapeutic target to treat Alzheimer’s disease identified in 2022 by Indiana University School of Medicine researchers will now be translated to a clinical trial, spearheaded through a collaboration between IU School of Medicine scientists and clinicians.
May 22, 2024